These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15966776)

  • 21. Evaluation of metered dose inhaler spray velocities using phase Doppler anemometry (PDA).
    Liu X; Doub WH; Guo C
    Int J Pharm; 2012 Feb; 423(2):235-9. PubMed ID: 22183132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug.
    Abdou EM; Kandil SM; Morsi A; Sleem MW
    Drug Deliv; 2019 Dec; 26(1):689-699. PubMed ID: 31274014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of expansion chamber geometry on atomization and spray dispersion characters of a flashing mixture containing inerts. Part II: High speed imaging measurements.
    Ju D; Shrimpton J; Bowdrey M; Hearn A
    Int J Pharm; 2012 Aug; 432(1-2):32-41. PubMed ID: 22579579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.
    Gupta A; Stein SW; Myrdal PB
    J Aerosol Med; 2003; 16(2):167-74. PubMed ID: 12823910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.
    Liao YH; Brown MB; Jones SA; Nazir T; Martin GP
    Int J Pharm; 2005 Nov; 304(1-2):29-39. PubMed ID: 16181753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel formulation technique for metered dose inhaler (MDI) suspensions.
    Steckel H; Wehle S
    Int J Pharm; 2004 Oct; 284(1-2):75-82. PubMed ID: 15454299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation and evaluation of albuterol metered dose inhalers containing tetrafluoroethane (P134a), a non-CFC propellant.
    Tiwari D; Goldman D; Malick WA; Madan PL
    Pharm Dev Technol; 1998 May; 3(2):163-74. PubMed ID: 9653753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimized dose delivery of the peptide cyclosporine using hydrofluoroalkane-based metered dose inhalers.
    Myrdal PB; Karlage KL; Stein SW; Brown BA; Haynes A
    J Pharm Sci; 2004 Apr; 93(4):1054-61. PubMed ID: 14999741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the metering chamber volume and actuator design on the aerodynamic particle size of a metered dose inhaler.
    Berry J; Heimbecher S; Hart JL; Sequeira J
    Drug Dev Ind Pharm; 2003 Sep; 29(8):865-76. PubMed ID: 14570307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
    Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
    Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the Feasibility of Rugose Lipid Microparticles in Pressurized Metered Dose Inhalers with Established and New Propellants.
    Minootan Z; Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Martin AR; Vehring R
    AAPS PharmSciTech; 2024 Apr; 25(4):82. PubMed ID: 38600288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles.
    Chokshi U; Selvam P; Porcar L; da Rocha SR
    Int J Pharm; 2009 Mar; 369(1-2):176-84. PubMed ID: 19028557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the valve lubricant on the aerodynamic particle size of a metered dose inhaler.
    Berry J; Kline L; Naini V; Chaudhry S; Hart J; Sequeira J
    Drug Dev Ind Pharm; 2004 Mar; 30(3):267-75. PubMed ID: 15109026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
    Chopra N; Williams M; Rimmer M; Kahl L; Jenkins M;
    Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of expansion chamber geometry on atomization and spray dispersion characters of a flashing mixture containing inerts. Part I. Numerical predictions and dual laser measurements.
    Ju D; Shrimpton J; Bowdrey M; Hearn A
    Int J Pharm; 2012 Aug; 432(1-2):23-31. PubMed ID: 22575753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.
    Wu L; Al-Haydari M; da Rocha SR
    Eur J Pharm Sci; 2008 Feb; 33(2):146-58. PubMed ID: 18083015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug distribution transients in solution and suspension-based pressurised metered dose inhaler sprays.
    Duke DJ; Scott HN; Kusangaya AJ; Kastengren AL; Matusik K; Young P; Lewis D; Honnery D
    Int J Pharm; 2019 Jul; 566():463-475. PubMed ID: 31173800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers.
    Smyth HD; Beck VP; Williams D; Hickey AJ
    AAPS PharmSciTech; 2004 Feb; 5(1):E7. PubMed ID: 15198528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.